Bionano will host a webinar featuring the study’s lead author, Dr. Guilin Tang, who will discuss the study and its findings in ...
Bionano Genomics (BNGO) announced a study published in the American Journal of Hematology demonstrating the potential utility of optical genome ...
Hosted on MSN1mon
Bionano Genomics ends sales agreement with CowenBionano Genomics (NASDAQ:BNGO), Inc., a company specializing in laboratory analytical instruments, has terminated a material definitive agreement with Cowen and Company, LLC. This termination ...
SAN DIEGO, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO)(the “Company”) today announced that it will effect a reverse stock split of its issued and outstanding common ...
Hosted on MSN1mon
Bionano Genomics announces 1-for-60 reverse stock splitGene sequencing company Bionano Genomics (NASDAQ:BNGO) traded ~8% lower in the premarket on Thursday after announcing a 1-for-60 reverse stock split that will take effect on Friday at 5 p.m. In a ...
Bionano Genomics (NASDAQ:BNGO – Get Free Report) is expected to announce its earnings results before the market opens on Wednesday, March 12th.Analysts expect the company to announce earnings of ...
SAN DIEGO, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO)(the “Company”) today announced that it will effect a reverse stock split of its issued and outstanding common ...
Bionano Genomics, Inc. (NASDAQ: BNGO) shares are trading lower Monday. The company's stock began trading on a reverse split-adjusted basis on Monday. Erica Kollmann Over $1M Bet On Bioventus?
Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space. The firm engages in the development and marketing of the Saphyr system, a platform ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results